Abstract
In the rapidly evolving landscape of artificial intelligence (AI) in healthcare, the study explores the diagnostic capabilities of Generative Pre-trained Transformer 4 Vision (GPT-4V) in complex clinical scenarios involving both medical imaging and textual patient data. Conducted over a week in October 2023, the study employed 93 cases from the New England Journal of Medicine’s image challenges. These cases were categorized into four types based on the nature of the imaging data, ranging from radiological scans to pathological slides. GPT-4V’s diagnostic performance was evaluated using multimodal inputs (text and image), text-only, and image-only prompts. The results indicate that GPT-4V’s diagnostic accuracy was highest when provided with multimodal inputs, aligning with the confirmed diagnoses in 80.6% of cases. In contrast, text-only and image-only inputs yielded lower accuracies of 66.7% and 45.2%, respectively (after correcting for random guessing: multimodal: 70.5 %, text only: 54.3 %, image only: 29.3 %). No significant variation was observed in the model’s performance across different types of images or medical specialties. The study substantiates the utility of multimodal AI models like GPT-4V as potential aids in clinical diagnostics. However, the proprietary nature of the model’s training data and architecture warrants further investigation to uncover biases and limitations. Future research should aim to corroborate these findings with real-world clinical data while considering ethical and privacy concerns.
Competing Interest Statement
No funding. W.W. is inventor of the patent WO2017020982A1 Agents for use in the treatment of glioma. This patent covers new treatment strategies that all target the formation and function of TMs in glioma.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
No patient data was used in this study. Image challenges and their solutions are publicly available at https://www.nejm.org/image-challenge. Software for using the Open AI API has been deposited on GitHub at https://github.com/venkataramani-lab/ImageChallenges.
